Skip to main content
Premium Trial:

Request an Annual Quote

IBM and Karolinska Institute to Build Biobank in Sweden

NEW YORK, Nov. 17 (GenomeWeb News) - The Karolinska Institute and IBM have teamed up to build a biobank in Sweden, the partners said today.


The Karolinska Institute Biobank, which will be part of a strategic alliance between the Stockholm-based research institute and IBM, aims to integrate research projects across Swedenby developing data-collection standards and providing an IT infrastructure. The aim also is to integrate genotypic and phenotypic data.


The biobank will serve as a core facility, helping researchers comply with the laws regulating biobanking. IBM will provide consulting services as well as a variety of hardware from the company's Healthcare and Life Sciences Clinical Genomics Solution.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.